Nanogen, Fisher expand molecular diagnostics collaboration

By Elaine Rigoli

Tampa, Fla., Aug. 3 - Nanogen, Inc. and Fisher Scientific International, Inc. have expanded their relationship and will now share technology and patent rights specifically for the development, manufacture and marketing of new molecular diagnostic products.

Under the agreement, Fisher may provide up to $10 million during 2007 and 2008 for the research and development of infectious disease and molecular diagnostic tests that will be mutually agreed upon, according to a news release.

Additionally, Nanogen and Athena Diagnostics, a wholly owned subsidiary of Fisher, have agreed to develop, manufacture and market products based on Athena's proprietary biomarkers for research and for in-vitro diagnostic use.

Nanogen develops diagnostic products and is based in San Diego.

Fisher is a provider of products and services to the scientific community and has headquarters in Hampton, N.H.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.